FMI
Income statement / Annual
Last year (2017), Foundation Medicine, Inc.'s total revenue was $152.90 M,
an increase of 30.84% from the previous year.
In 2017, Foundation Medicine, Inc.'s net income was -$143.47 M.
See Foundation Medicine, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
| Period Ended |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
| Operating Revenue |
$152.90 M |
$116.87 M |
$93.20 M |
$61.08 M |
$28.99 M |
$10.65 M |
$2.06 M |
| Cost of Revenue |
$85.27 M
|
$56.75 M
|
$39.43 M
|
$27.43 M
|
$11.66 M
|
$5.68 M
|
$258.00 K
|
| Gross Profit |
$67.63 M
|
$60.12 M
|
$53.77 M
|
$33.65 M
|
$17.33 M
|
$4.96 M
|
$1.80 M
|
| Gross Profit Ratio |
0.44
|
0.51
|
0.58
|
0.55
|
0.6
|
0.47
|
0.87
|
| Research and Development Expenses |
$91.51 M
|
$67.37 M
|
$43.88 M
|
$30.63 M
|
$24.90 M
|
$14.78 M
|
$9.02 M
|
| General & Administrative Expenses |
$70.34 M
|
$48.61 M
|
$50.61 M
|
$27.30 M
|
$21.87 M
|
$8.64 M
|
$6.99 M
|
| Selling & Marketing Expenses |
$66.73 M
|
$57.95 M
|
$49.03 M
|
$29.00 M
|
$12.33 M
|
$3.45 M
|
$1.56 M
|
| Selling, General & Administrative Expenses |
$137.07 M
|
$106.56 M
|
$99.64 M
|
$56.30 M
|
$34.19 M
|
$12.10 M
|
$8.55 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$228.58 M
|
$173.93 M
|
$143.53 M
|
$86.93 M
|
$59.09 M
|
$26.88 M
|
$17.57 M
|
| Cost And Expenses |
$313.85 M
|
$230.68 M
|
$182.96 M
|
$114.36 M
|
$70.75 M
|
$32.56 M
|
$17.83 M
|
| Interest Income |
$0.00
|
$624.00 K
|
$124.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$727.00 K
|
$0.00
|
$0.00
|
$42.00 K
|
$235.00 K
|
$421.00 K
|
$421.00 K
|
| Depreciation & Amortization |
-$204.00 K
|
$15.95 M
|
$10.60 M
|
-$1.10 M
|
$948.00 K
|
$2.89 M
|
$1.52 M
|
| EBITDA |
-$160.94 M |
-$113.82 M |
-$89.76 M |
-$53.28 M |
-$40.81 M |
-$19.02 M |
-$14.25 M |
| EBITDA Ratio |
-1.05
|
-0.97
|
-0.96
|
-0.87
|
-1.41
|
-1.79
|
-6.93
|
| Operating Income Ratio |
-1.05
|
-0.97
|
-0.96
|
-0.87
|
-1.44
|
-2.06
|
-7.67
|
| Total Other Income/Expenses Net |
-$523.00 K
|
$624.00 K
|
$124.00 K
|
$1.06 M
|
-$1.18 M
|
-$482.00 K
|
-$1.27 M
|
| Income Before Tax |
-$161.47 M
|
-$113.19 M
|
-$89.63 M
|
-$52.22 M
|
-$42.94 M
|
-$22.39 M
|
-$17.04 M
|
| Income Before Tax Ratio |
-1.06
|
-0.97
|
-0.96
|
-0.85
|
-1.48
|
-2.1
|
-8.28
|
| Income Tax Expense |
-$17.99 M
|
-$16.57 M
|
-$10.72 M
|
-$9.26 M
|
-$3.82 M
|
$0.00
|
$0.00
|
| Net Income |
-$143.47 M
|
-$96.62 M
|
-$78.91 M
|
-$42.97 M
|
-$39.12 M
|
-$22.39 M
|
-$17.04 M
|
| Net Income Ratio |
-0.94
|
-0.83
|
-0.85
|
-0.7
|
-1.35
|
-2.1
|
-8.28
|
| EPS |
-4 |
-2.78 |
-2.4 |
-1.54 |
-4.21 |
-7.3 |
-5.56 |
| EPS Diluted |
-4 |
-2.78 |
-2.4 |
-1.54 |
-4.21 |
-7.3 |
-5.56 |
| Weighted Average Shares Out |
$35.88 M
|
$34.79 M
|
$32.84 M
|
$27.95 M
|
$9.29 M
|
$3.07 M
|
$3.07 M
|
| Weighted Average Shares Out Diluted |
$35.88 M
|
$34.79 M
|
$32.84 M
|
$27.95 M
|
$9.29 M
|
$3.07 M
|
$3.07 M
|
| Link |
|
|
|
|
|
|
|
